Influence of TNF-alpha on the efficacy of anemia correction in patients with lymphoproliferative disorders
In this article mechanisms of anaemia development in patients with lymphatic tissue malignant diseases are presented. Therapy efficacy of erythropoiesis-stimulating agents (EPO) in patients with lymphoproliferative disorders and anaemia (n = 21) is studied. Study group included patients with a chron...
Saved in:
| Main Authors: | N. A. Romanenko, S. S. Bessmeltsev, O. E. Rozanova, N. S. Karpova, K. M. Abdulkadyrov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-11-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/731 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01) -
Eprex in the management of anemia related to lymphoproliferative disorders
by: P. N. Barlamov, et al.
Published: (2022-11-01) -
Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01) -
Risk of hematologic malignancies in psoriasis and rheumatoid arthritis patients using long term TNF-α inhibitors: a retrospective nationwide study
by: Jihun Song, et al.
Published: (2025-03-01) -
Options for correcting nephrogenic anemia in a patient with HIV and chronic kidney disease. Case report
by: Victor V. Fomin
Published: (2024-11-01)